Norway· NO-ID_840BE971-CA9F-44CB-AC1E-CB0AFA98326C
Ajovy
A fremanezumab product containing fremanezumab, registered in Norway by Teva GmbH. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Fremanezumab is registered in 15 of 19 countries.
Countries holding a registration under ATC N02CD03 (fremanezumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Fremanezumab · ATC N02CD03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Fremanezumab
- Manufacturer
- Teva GmbH
- Country
- Norway (NO)
- ATC code
- N02CD03
- ATC class
- Fremanezumab
- Defined daily dose
- 7.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_840BE971-CA9F-44CB-AC1E-CB0AFA98326C
- no_varenummer3830371.5NOK 5043.8
- gtin7046263830377
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fremanezumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAJOVYTeva GmbH, Ulm
- SwedenAJOVY 225 mg Injektionsvätska, lösning i förfylld injektionspennaTEVA GmbH
- SpainAJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADATeva Gmbh
- IcelandAJOVYTEVA GmbH
- BelgiumAjovy 225 mgTeva
- SwitzerlandAJOVY 225 mg, Injektionslösung im FertigpenTeva Pharma AG
- PolandAjovyTEVA GmbH
- United StatesAJOVYTeva Pharmaceuticals USA, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Ajovy
- Iceland · Ajovy
- Liechtenstein · Ajovy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1d17151c-ba2f-445d-9fbd-2b8e3d0c60d4 GET /v1/drugs/1d17151c-ba2f-445d-9fbd-2b8e3d0c60d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning i ferdigfylt sprøyte",
"source": "fest",
"status": "A",
"atc_name": "Fremanezumab",
"merkevare_id": "ID_840BE971-CA9F-44CB-AC1E-CB0AFA98326C",
"name_form_strength": "Ajovy inj, oppl 225 mg/sprøyte",
"prescription_group": "C"
}See everything about fremanezumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.